Physician profile
Daniel R Lowe
NPI 1932373578
$4,311.43
in general payments reported to CMS, 2019-2025
38 companies · $475 in 2025
The $475 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $279 · 2021: $1,365 · 2022: $379 · 2023: $516 · 2024: $93.29 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $893.78 | 2019-2025 | Posluma |
| Astellas Pharma US INC | $604.79 | 2019-2022 | |
| Procept Biorobotics Corporation | $400.84 | 2019-2025 | Aquabeam Robotic System |
| Boston Scientific Corporation | $341.92 | 2019-2023 | Rezum Generator |
| Edap Technomed INC | $217.93 | 2019-2025 | |
| Pfizer INC. | $147.24 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $144.37 | 2019-2021 | |
| Abbvie INC. | $141.04 | 2022-2023 | |
| Neotract INC. | $136.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.98 | 2019-2021 | |
| Olympus America INC. | $97.13 | 2021-2025 | Itind System |
| Allergan, INC. | $92.75 | 2019-2022 | |
| Srs Medical Systems, INC. | $87.08 | 2023-2024 | Urocuff, Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Tolmar Pharmaceuticals, INC. | $79.96 | 2019-2021 | |
| Myovant Sciences INC. | $61.17 | 2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.